These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21942253)

  • 1. What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?
    Millan DS
    Future Med Chem; 2011 Oct; 3(13):1635-45. PubMed ID: 21942253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease.
    Norman P
    Expert Opin Investig Drugs; 2015 Mar; 24(3):383-92. PubMed ID: 25599809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.
    Chopra P; Kanoje V; Semwal A; Ray A
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1411-25. PubMed ID: 18808304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
    Medicherla S; Fitzgerald MF; Spicer D; Woodman P; Ma JY; Kapoun AM; Chakravarty S; Dugar S; Protter AA; Higgins LS
    J Pharmacol Exp Ther; 2008 Mar; 324(3):921-9. PubMed ID: 18056868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38 MAPK inhibitors: a patent review (2012 - 2013).
    Bühler S; Laufer SA
    Expert Opin Ther Pat; 2014 May; 24(5):535-54. PubMed ID: 24611721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapies for chronic obstructive pulmonary disease.
    Barnes PJ
    Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.
    Pargellis C; Regan J
    Curr Opin Investig Drugs; 2003 May; 4(5):566-71. PubMed ID: 12833650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
    Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
    Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinase inhibitors: a new approach to rheumatoid arthritis treatment.
    Cohen S; Fleischmann R
    Curr Opin Rheumatol; 2010 May; 22(3):330-5. PubMed ID: 20164774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.
    Norman P
    Expert Opin Ther Pat; 2014 Dec; 24(12):1397-407. PubMed ID: 25407284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.
    Barnes PJ
    Pharmacol Rev; 2016 Jul; 68(3):788-815. PubMed ID: 27363440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
    Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome.
    Ding C
    Curr Opin Investig Drugs; 2006 Nov; 7(11):1020-5. PubMed ID: 17117592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Busch-Petersen J; Lainé DI
    Future Med Chem; 2011 Oct; 3(13):1623-34. PubMed ID: 21942252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease.
    Millan DS; Bunnage ME; Burrows JL; Butcher KJ; Dodd PG; Evans TJ; Fairman DA; Hughes SJ; Kilty IC; Lemaitre A; Lewthwaite RA; Mahnke A; Mathias JP; Philip J; Smith RT; Stefaniak MH; Yeadon M; Phillips C
    J Med Chem; 2011 Nov; 54(22):7797-814. PubMed ID: 21888439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontrunners in novel pharmacotherapy of COPD.
    Barnes PJ
    Curr Opin Pharmacol; 2008 Jun; 8(3):300-7. PubMed ID: 18457992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
    Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
    J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMS-582949: crystalline form of a p38alpha inhibitor? WO2008079857.
    Norman P
    Expert Opin Ther Pat; 2009 Aug; 19(8):1165-8. PubMed ID: 19505194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS
    COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.